David Stein
Senior Director, Clinical Trial Management Regeneron
David Stein is Senior Director, Clinical Trial Management at Regeneron Pharmaceuticals, where he has built extensive experience in the biotechnology industry and clinical research. His expertise spans clinical trial management, FDA-related activities, electronic data capture, life sciences, and strategic planning. David holds a Bachelor of Science in Biological Sciences from Cornell University and brings a long-standing clinical operations perspective to the development and delivery of clinical research programs.
Seminars
Wednesday 24th March 2027
Maintaining Treatment Beyond the Clinical Trial: A Mibavademab Case Study in Global Post-Trial Access Planning
2:30 pm
- Using the mibavademab EAP as a case study to explore global post-trial access planning and treatment continuity
- Navigating differing regulatory requirements and access pathways across multiple countries
- Balancing governance, real-world data collection and cross-functional decisionmaking when implementing post-trial access globally
